ACER has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
ACER has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
6-1 Month Momentum % is the total return of the stock from 6-month ago to 1-month ago. As of today (2024-04-25), Acer Therapeutics's 6-1 Month Momentum % is -0.35%.
The industry rank for Acer Therapeutics's 6-1 Month Momentum % or its related term are showing as below:
For the Biotechnology subindustry, Acer Therapeutics's 6-1 Month Momentum %, along with its competitors' market caps and 6-1 Month Momentum % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Biotechnology industry and Healthcare sector, Acer Therapeutics's 6-1 Month Momentum % distribution charts can be found below:
* The bar in red indicates where Acer Therapeutics's 6-1 Month Momentum % falls into.
6-1 Month Momentum % is calculated as following:
6-1 Month Momentum % | = | ( Price 1-month ago | / | Price 6-month ago | - 1 ) | * | 100 % |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Acer Therapeutics (OTCPK:ACER) 6-1 Month Momentum % Explanation
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 6-1 Month Momentum % measures the total return to a stock over the past six months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
Thank you for viewing the detailed overview of Acer Therapeutics's 6-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.
Chris Schelling | director, officer: President and Chief Executive | C/O ACER THERAPEUTICS INC., 222 THIRD STREET, CAMBRIDGE MA 02142 |
Steve Aselage | director | 6300 DUMBARTON CIRCLE, FREMONT CA 94555 |
Tanya Hayden | officer: Chief Operating Officer | 300 WASHINGTON STREET, ONE GATEWAY CENTER, SUITE 351, NEWTON MA 02458 |
Adrian W Quartel | officer: Chief Medical Officer | 300 WASHINGTON STREET, ONE GATEWAY CENTER, SUITE 351, NEWTON MA 02458 |
Bernard H Paul | officer: Chief People Officer | 300 WASHINGTON STREET, ONE GATEWAY CENTER, SUITE 351, NEWTON MA 02458 |
Jefferson E Davis | officer: Chief Business Officer | 300 WASHINGTON STREET, ONE GATEWAY CENTER, SUITE 351, NEWTON MA 02458 |
John Michael Dunn | director | C/O VITAL THERAPIES, INC., 15010 AVENUE OF SCIENCE, SUITE 200, SAN DIEGO CA 92128 |
Donald Joseph | officer: Chief Legal Officer and Secy | C/O KALOBIOS PHARMACEUTICALS, INC., 260 EAST GRAND AVENUE, SOUTH SAN FRANCISCO CA 94080 |
John Michael Klopp | officer: Chief Technology Officer | ONE GATEWAY CENTER, SUITE 351, 300 WASHINGTON STREET, NEWTON MA 02458 |
Matthew Seibt | officer: Chief Commercial Officer | ONE GATEWAY CENTER, SUITE 351, 300 WASHINGTON STREET, NEWTON MA 02458 |
Michelle Renee Griffin | director | 19723 NE 65TH LANE, KIRKLAND WA 98033 |
Harry S Palmin | officer: Chief Opp. and Financial Offr | C/O NOVELOS THERAPUETICS, INC., ONE GATEWAY CENTER,SUITE 504, NEWTON MA 02458 |
William T. Andrews | officer: Chief Medical Officer | ONE MAIN STREET, SUITE 800, CAMBRIDGE MA 02142 |
Jason Amello | director | 500 KENDALL STREET, CAMBRIDGE MA 01824 |
Salma Jutt-eghbali | officer: Chief Commercial Officer | ONE GATEWAY CENTER, SUITE 351, 300 WASHINGTON STREET, NEWTON MA 02458 |
From GuruFocus
By Value_Insider Value_Insider • 11-14-2022
By Stock market mentor Stock market mentor • 01-09-2023
By Marketwired • 06-26-2023
By Tiesvg Tiesvg • 12-29-2022
By PRNewswire • 08-31-2023
By Business Wire • 10-10-2023
By sperokesalga sperokesalga • 02-13-2023
By sperokesalga sperokesalga • 05-15-2023
By Value_Insider Value_Insider • 10-26-2022
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.